Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
85.00
Ask:
100.00
Spread: 15.00 (17.647%)
Market Cap: £13.28m
MAI Live PriceLast checked at - London Stock Exchange

Intraday Maintel Share Chart

Trading Statement

2 Feb 2012 07:00

RNS Number : 6454W
Maintel Holdings PLC
02 February 2012
 

Maintel Holdings Plc

("Maintel" or the "Group")

 

Trading Statement

 

 

Maintel, the telecoms and data services company, is pleased to report that trading profits for the year to 31 December 2011 are expected to be moderately ahead of market expectations. The Group has achieved robust levels of growth during the period and has seen improved profitability in its Maintenance and Network Services divisions, as well as an encouraging initial contribution from Totility.

 

In addition, we have seen a solid start to 2012, with healthy new order pipelines across the Group. Furthermore, the integration of Totility is progressing well and initial cross selling is proving successful. 

 

Notwithstanding the broader macro economic environment, we are confident in our financial outlook for the year ahead. 

 

 

 

 

2 February 2012

 

 

 

 

Enquiries:

Eddie Buxton - Chief Executive 020 7401 4601

Dale Todd - Finance Director 020 7401 0562

Marc Young - FinnCap 020 7600 1658

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGGZNMDGZZM
Date   Source Headline
3rd Jun 20267:00 amRNSNotice of AGM
1st Jun 20264:44 pmRNSResult of General Meeting
29th May 20262:03 pmRNSResult of Retail Offer and Update on Timing
13th May 20262:35 pmRNSRetail Offer
13th May 20262:30 pmRNSPlacing and Issue of Convertible Loan Notes
11th Feb 20263:26 pmRNSWithdrawal of Requisition
27th Jan 20267:00 amRNSRequisition of General Meeting
22nd Jan 20267:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Results
8th Sep 20257:00 amRNS-RNotice of Investor Presentation
3rd Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAppointment of Non-Executive Chair
6th Aug 20257:00 amRNS-RAppointment of Chief Operating Officer
29th Jul 20257:00 amRNSTrading Update and Notice of Results
3rd Jun 20255:32 pmRNSResult of Annual General Meeting
3rd Jun 20257:00 amRNSAGM Trading Update
15th May 20257:00 amRNS-RYellowstone Advisory Private Investor Evening
12th May 20257:00 amRNSGrant of Options
8th May 20254:47 pmRNSAnnual Report and Notice of AGM
6th May 20257:00 amRNS2024 Annual Audited Results
2nd May 20257:00 amRNS-RNotice of Investor Presentation
1st May 20257:00 amRNSNotice of Annual Results
22nd Apr 20257:00 amRNSChange of Registered Office
25th Feb 20257:00 amRNSAppointment of Chief Executive Officer
31st Jan 20257:00 amRNSTrading Update
19th Sep 20247:00 amRNSInterim Results
7th Aug 20247:00 amRNSTrading Update and Notice of Results
3rd Jul 20247:00 amRNSAppointment of Non-Executive Directors
19th Jun 20242:24 pmRNSResult of AGM
19th Jun 20247:00 amRNSAGM Trading Update
10th May 20245:02 pmRNSAnnual Report and Notice of AGM
3rd May 202410:01 amRNSPublication of Annual Report
1st May 20247:00 amRNSFinal Results
18th Apr 202412:30 pmRNSBoard Changes
18th Apr 20247:00 amRNSNotice of Final Results
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSBoard Changes
22nd Jan 20247:00 amRNSTrading Update and Notice of Results
16th Oct 20234:15 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSDirector/PDMR Shareholding
19th Sep 20231:34 pmRNSReplacement: Interim results
19th Sep 20237:00 amRNSInterim results
4th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading update and Notice of Results
30th May 20235:25 pmRNSResults of AGM and Board Changes
30th May 20231:03 pmRNSAGM Statement
11th May 20232:20 pmRNSDirector Appointment
4th May 20235:15 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSGrant and Surrender of Options
27th Apr 20237:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.